Opioid-addiction care of medication and counseling could cut deaths by 16.9% and save up to $105,000 over lifetime of a patient’s care, study shows.
A Stanford Medicine researcher finds that the Affordable Care Act's insurance subsidies have protected low-income Americans against high medical costs.
A Stanford-led study found that deforestation declined in a Indonesian community after a health clinic provided an incentive to avoid illegal logging.
Stanford health economist Kevin Schulman examines how inefficiencies in the health care system affect the nation and individuals — including his own family.
The year-long curriculum encourages students to seek innovative solutions to reduce the cost of high-quality health care in the United States.
In this 1:2:1 podcast, host Paul Costello discusses drug shortages with Stanford and Veterans Affairs anesthesiologist Ed Mariano.
Writer Adam Hochschild reflects on a health care experience abroad that underscores the "absurdities" of the American medical system.
Government subsidies in Affordable Care Act marketplaces incentivize insurers to manipulate prices based on individuals' income, study finds.
Health care policy issues are at the top of U.S. lawmakers' agendas, Congresswoman Zoe Lofgren (D-Calif.) says during a Stanford Health Policy Forum.
As physician Ilana Yurkiewicz writes, it can be challenging to treat a patient with a hematological emergency who is concerned about the cost of care.
New Stanford research has found that larger practices with several specialities have the potential to reduce the cost of care for Medicare patients.
In a recent commentary, Victor Fuchs, known as the dean of health economics, explains how health insurance linked to employment skews health care costs
If physicians follow the guidelines for patients with leg and lower back pain and wait before getting MRIs, it could save half a billion dollars a year.
A Stanford study has found that mandated public disclosure of physicians' financial ties may have diminished trust in all physicians.
Health spending in the U.S. is projected to accelerate in the next decade. Stanford professor Kevin Schulman offers an explanation.
Retail prices at pharmacies may bear little relationship to the actual market prices of medications, and pharmacy benefit managers are part of the reason.